Major recent improvements in a number of imaging techniques enable studying the brain in ways that could not be considered previously. Today, with MILabs’ new multimodality neuromics platform, researchers have well-developed and complementary tools for in vivo structural and functional imaging of the rodent brain in action. More specifically, now you can:
Examine the dynamic nature of vascular responses and brain perfusion.
Study neuroreceptor kinetics at ultra-high resolution with SPECT in species ranging from mice to large non-human primates.
Gain new insights into brain (dys)functions by simultaneously performing spatially and temporally co-registered PET and SPECT acquisitions.
Probe neurodegeneration with in vivo bioluminescence and fluorescence imaging.
Replace labor-intensive and error-prone neural tissue examinations by automated 3D multi-tracer autoradiography.
Perform SPECT/CT and PET/CT at ultra-high resolutions critical for studying structures that fall well below the threshold of other preclinical hybrid scanners.
Best of all, you just need one single imaging platform, the MILabs PET/SPECT/OI/CT (VECTor-OI/CT) system, to make this all possible.
MILabs’ VECTor-OI/CT system makes anatomical, functional and molecular neuromics evaluation possible in a completely non-invasive way.
MILabs products are used in more than 65 countries and are supported by a global network of distributors and factory trained support engineers.
Please contact MILabs directly for more information about your local MILabs business partner.